MPWT
CRL icon

MassMutual Private Wealth & Trust’s Charles River Laboratories CRL Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87.3K Sell
385
-1
-0.3% -$178 ﹤0.01% 614
2026
Q1 		$66.6K Sell
386
-72
-16% -$13.3K ﹤0.01% 673
2025
Q4 		$91.4K Sell
458
-201
-31% -$36.5K ﹤0.01% 616
2025
Q3 		$103K Sell
659
-1,216
-65% -$193K ﹤0.01% 587
2025
Q2 		$284K Buy
1,875
+464
+33% +$61.9K 0.01% 391
2025
Q1 		$212K Buy
1,411
+324
+30% +$54.3K 0.01% 422
2024
Q4 		$201K Sell
1,087
-755
-41% -$145K 0.01% 455
2024
Q3 		$363K Buy
1,842
+79
+4% +$16.4K 0.01% 337
2024
Q2 		$364K Buy
1,763
+1,532
+663% +$347K 0.01% 339
2024
Q1 		$62.6K Sell
231
-97
-30% -$23.2K ﹤0.01% 571
2023
Q4 		$77.5K Buy
328
+58
+21% +$11.4K ﹤0.01% 512
2023
Q3 		$52.9K Buy
270
+52
+24% +$10.7K ﹤0.01% 574
2023
Q2 		$45.8K Buy
218
+71
+48% +$14.1K ﹤0.01% 555
2023
Q1 		$29.7K Buy
147
+1
+0.7% +$227 ﹤0.01% 623
2022
Q4 		$32K Buy
146
+12
+9% +$2.62K ﹤0.01% 539
2022
Q3 		$26K Sell
134
-7
-5% -$1.51K ﹤0.01% 544
2022
Q2 		$30K Buy
141
+14
+11% +$3.42K ﹤0.01% 514
2022
Q1 		$36K Sell
127
-6
-5% -$1.85K ﹤0.01% 503
2021
Q4 		$50K Hold
133
– – ﹤0.01% 482
2021
Q3 		$55K Sell
133
-12
-8% -$4.98K ﹤0.01% 474
2021
Q2 		$54K Buy
145
+110
+314% +$36.7K ﹤0.01% 465
2021
Q1 		$10K Buy
+35
New +$9.73K ﹤0.01% 601
2020
Q1 		– Sell
-91
Closed -$14K – 689
2019
Q4 		$14K Sell
91
-34
-27% -$4.71K ﹤0.01% 567
2019
Q3 		$17K Hold
125
– – ﹤0.01% 527
2019
Q2 		$18K Hold
125
– – ﹤0.01% 505
2019
Q1 		$18.2K Sell
125
-5
-4% -$657 ﹤0.01% 521
2018
Q4 		$14.7K Sell
130
-29
-18% -$3.63K ﹤0.01% 517
2018
Q3 		$21.4K Sell
159
-3,222
-95% -$398K ﹤0.01% 497
2018
Q2 		$380K Buy
3,381
+183
+6% +$19.8K 0.03% 289
2018
Q1 		$341K Buy
3,198
+309
+11% +$33.3K 0.03% 284
2017
Q4 		$316K Buy
2,889
+65
+2% +$7.07K 0.03% 296
2017
Q3 		$305K Buy
2,824
+131
+5% +$13.5K 0.03% 309
2017
Q2 		$272K Sell
2,693
-46
-2% -$4.23K 0.02% 303
2017
Q1 		$246K Buy
2,739
+130
+5% +$11K 0.02% 315
2016
Q4 		$199K Buy
+2,609
New +$198K 0.02% 276
2016
Q2 		$233K Buy
2,828
+59
+2% +$4.86K 0.03% 297
2016
Q1 		$210K Buy
2,769
+117
+4% +$8.66K 0.03% 288
2015
Q4 		$213K Buy
2,652
+545
+26% +$39.3K 0.03% 268
2015
Q3 		$126K Buy
2,107
+51
+2% +$3.66K 0.03% 303
2015
Q2 		$110K Sell
2,056
-405
-16% -$30K 0.02% 310
2015
Q1 		$195K Buy
2,461
+2,411
+4,822% +$178K 0.03% 277
2014
Q4 		$3.18K Sell
50
-2,057
-98% -$129K ﹤0.01% 538
2014
Q3 		$126K Buy
2,107
+2,057
+4,114% +$118K 0.03% 298
2014
Q2 		$2.68K Hold
50
– – ﹤0.01% 486
2014
Q1 		$3.02K Buy
+50
New +$2.92K ﹤0.01% 464

Other funds holding CRL

CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
JPMIA
J.P. Marvel Investment Advisors Boston, Massachusetts $871M AUM 64.45% 1-Year Est. Return

MassMutual Private Wealth & Trust's CRL Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Charles River Laboratories (CRL) stake by 0.26% in Q2 2026, selling an estimated $178 and leaving 385 shares worth $87.3K. The position accounts for ﹤0.01% of the portfolio, ranked #614.

MassMutual Private Wealth & Trust first reported a position in CRL in Q1 2014 and has held it in 45 quarters since. The position peaked at $380K in Q2 2018. 173 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • MassMutual Private Wealth & Trust held 385 shares of Charles River Laboratories worth $87.3K as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 1 Charles River Laboratories share in Q2 2026, an estimated $178.
  • Charles River Laboratories made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #614 holding.
  • MassMutual Private Wealth & Trust first reported a position in Charles River Laboratories in Q1 2014 and has held it in 45 quarters since.
  • MassMutual Private Wealth & Trust's Charles River Laboratories position peaked at $380K in Q2 2018.
  • 173 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.